Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
22 October 2024 | Story Precious Shamase and Bulelwa Moikwathai | Photo Supplied
DHET international scholarship sessions 2024
Bulelwa Moikwaikwatlhai , Assistant Director: International Office and Dr Temwa Moyo, acting Director for International Scholarships at DHET.

The University of the Free State (UFS) Qwaqwa Campus recently hosted two information sessions on international scholarships, led by the Department of Higher Education and Training (DHET). These sessions were initiated by the Office for international Affairs.

In his welcoming address during the first information session for campus heads of department, Campus Vice-Principal: Support Services, Teboho Manchu, expressed his enthusiasm for the event and its potential benefits for students and staff. He emphasised the importance of these sessions in fostering growth and development. “We are looking forward to these engagements and hope that they will benefit all of us. Please feel welcome. I would also like to thank the Office for International Affairs and all the colleagues who have been working with them to make this interaction possible.”

Dr Temwa Moyo, acting Director for International Scholarships at the DHET, gave a comprehensive presentation on Erasmus+ programmes, which provide universities with opportunities and funding to collaborate on curriculum development for new programmes, capacity building in higher education, and full scholarships for joint master’s degrees, to name a few.

“The UFS has a significant international footprint, including on the African continent. Our department’s role is to stimulate international collaboration among institutions and to strengthen national collaborations to share best practices and build networks and capacity. This is the idea of the Erasmus + programmes,” explained Dr Moyo.

The DHET representative emphasised the department’s commitment to fostering international collaboration among universities and institutions. He explained that the Erasmus+ programmes aim to empower institutions and capacitate them to engage globally.

In the second student-centred session, Prof Ralph Clark, Director of the Afromontane Research Unit, encouraged students to take advantage of these opportunities because they enhance one’s networks, perspectives, and knowledge, as well as provide a platform for students to participate in and contribute to conversations and activities aimed at addressing global challenges with societal impact. The event provided attendees with various international opportunities through the DHET to support their academic pursuits. Students and staff learned about the benefits of studying abroad, the requirements, and the application process. The DHET’s emphasis on institutional partnerships also highlights the possibility of enriching academic exchange and cultural experiences.

Overall, the DHET international scholarship sessions on the UFS Qwaqwa Campus were a resounding success, with both students and staff attending in numbers. These sessions inspired students and staff to explore the exciting possibilities of global engagements.

News Archive

DNA sequencer launched at the UFS
2013-11-25

Dr Gansen Pillay, Deputy Chief Executive Officer of the National Research Foundation, explaining to the scholars what will be expected of them.

The University of the Free State (UFS) can now collect immensely valuable data on drug resistance in HIV/Aids and TB with the new DNA sequencer that was launched recently at the International workshop on HIV/AIDS and TB drug resistance at the Bloemfontein Campus.

The DNA sequencer will allow the Free State province to produce viral and bacterial genetic data to fight the local development of HIV/ Aids and TB drug resistance.

The HIV and TB epidemics have expanded very fast and South Africa now has the largest HIV and TB treatment programme in the world, with over 2 million patients on treatment. However, these successful treatment programmes are now being threatened by the appearance of drug resistance.

The Free State province has been at the forefront of fighting HIV drug resistance in South Africa and has one of the most advanced treatment programmes for the management of resistance strains in the country. In addition, researchers at the University of the Free State are leading partners in the Southern African Treatment and Resistance Network (SATuRN; www.bioafrica.net/saturn), a research network that has trained over 2 000 medical officers in the treatment of drug resistance strains.

The Department of Medical Microbiology and Virology in the Medical School at the UFS has partnered with the provincial department of health, the Medical Research Council (MRC) and the Delegation of the European Union to South Africa to fund a dedicated DNA sequencer machine that will be used to generate HIV and TB drug-resistance results. This new machine will enable cutting-edge research to take place, using the data in the province and, importantly, support patients with resistance strains to have access to advanced genotypic testing techniques.

“HIV drug resistance is a very serious problem in South Africa, and the recent advances in DNA testing technology allow clinicians in the province to access drug resistance testing, which enables them to manage patients appropriately who fail treatment, and use the results to cost-effectively extend and improve patients’ lives,” says Dr Cloete van Vuuren, Specialist in Infectious Diseases at the UFS’s Faculty of Health.

Dr Dominique Goedhals, pathologist from the Department of Medical Microbiology and Virology at the UFS, adds: “We have been looking forward to expanding our work with the clinicians and researchers, using DNA sequencing to shed light on the causes and consequences of drug resistance in urban and rural settings in the province.”

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept